This paper describes the development of a graphical user-interface (GUI) designed
I. INTRODUCTION
The user interface is where carbon-based humans, silicon-based computers, 1 and knowledge-based software meet. As any computer-alchemist can tell you, combining such disparate elements along with knowledge (an always elusive quantity) in an attempt to produce gold (in our case the correct drug dose) is difficult if not impossible. The relatively recent development of graphical user interfaces (GUI) is an attempt to diminish the blast when these three elements fuse.
Not withstanding the myriad problems associated with developing graphical userinterfaces for medical computing systems, there are also numerous problems in determining the correct dose of certain potentially toxic antibiotics. Various methods have been developed to help physicians determine the appropriate aminoglycoside dose for a specific patient. 2 This paper describes a prototype graphical user interface to one of the existing bayesian-based pharmacokinetic modelling programs. 3 II. BACKGROUND
User-Interfaces
In SteM's review of a quarter century of computer-based medical records he identified the foreign nature of man-machine interactions (of which the user-interface is an essential component) as one of the primary limitations to development and use of operational computing systems in healthcare. 4 The problems of the user-interface have not gone unnoticed or unresearched.
The first interactive computer systems communicated with the user through teletypewriters (TTYs). 5 These character-based terminals typed one letter after another on paper. Improvements in technology led to use of video display terminals (VDTs). These "glass TTYs" could position a character anywhere on the screen. These so-called, command line interfaces (CLI), have been the industry standard means of interactively executing programs for over 40 years. The increasing complexity of recently developed medical software requires a much more powerful and efficient means of entering and viewing data. 6 In April 1981, Xerox Corporation announced the first graphical user-interface (GUI) as part of the innovative 8010 Star Information system. 7 This system, developed by researchers at the XEROX PARC Institute over a 5-year period, introduced key components of GUIs including: (1) a mouse pointing device, (2) pull-down and pop-up menus, (3) a wide assortment of icons, buttons, sliding bars, etc., (4) the desktop metaphor, and (5) a high-resolution (for its day) video display unit.
An excellent example of one of these new graphical user-interfaces is described by Higgins et al. s They present a prototype graphical workstation for use by clinicians in an ICU. Of particular interest is the innovative use of commercially available software tools which allowed them to develop a working prototype rapidly. Their prototype enabled them to refine the application iteratively to create an impressive array of graphic displays and data entry forms.
Gentamicin Dosing
Gentamicin, an aminoglycoside antibiotic, is commonly used to treat life-threatening infections caused by gram-negative bacteria. Unfortunately, it has a narrow therapeutic range (i.e., blood concentrations which are both safe and effective). In addition, interindividual variations in drug metabolism can result in large differences in blood concentrations for patients of similar weight and age. Determining the proper initial and maintenance dosages is difficult.
For example, in a study conducted at Stanford University, researchers found that less than 40% of the patients receiving gentamicin, during a one-month study period, reached therapeutic blood levels and an additional 12% of the patients had blood concentrations (either peak or trough) above the therapeutic range. 9 In another study conducted in Germany, researchers again found that only 40% of patients' peak tobramycin (another aminoglycoside antibiotic) serum levels were within the therapeutic range, l° Based on studies such as these, many algorithms have been developed to aid clinicians in the difficult task of determining the appropriate doses.
Programs for Gentamicin Dosing and Their Interfaces
There are two general approaches to building programs to help determine the appropriate aminoglycoside dosing regimen: mathematical models and artificial intelligence (AI). Mathematical models provide ~a robust foundation for representing the interrelationships between dose, drug concentration, time between doses, and the pharmacodynamics of the patient. AI techniques provide the best current methods for incorporating other clinical information describing the patient into the dose determination algorithm. In 1992, Lenert et al. proposed a combination of these two techniques. 9 Regardless of which internal structure one uses to calculate the appropriate drug regimen, the user-interface is still a problem.
Zielmann et al. developed a programmed pocket calculator (PPC) which significantly improved the individualization of these drug doses. 1 ~ Farr and Shachter developed the rudiments of an aminoglycoside dosing program interface to collect preferenceassessment data on preferred dosage regimens. 12 An interesting feature of their program is that it allows the physician to change dose and timing data and immediately view the effect on the projected drug levels. Lenert et al. also developed an interface to their program, although they do not allow the user to change different patient parameters and instantaneously see the change. They do however, show the expected drug levels for several different dosing regimens.
Perhaps the most widely used clinical program (referred to as USC*PACK) for making these calculations was developed by Jelliffe et al. over the past 20 years. 13 The majority of their research time and effort has gone into development of the underlying models, rather than the user-interface. In fact, Okamoto notes that the USC*PACK PC-based programs provide information regarding the appropriate dose when target serum drug concentrations are given, "but [it] is more tedious and time consuming" to use [than other programs]. 13 We undertook this project to begin remedying that situation.
III. DESIGN CONSIDERATIONS
"If an error is possible, someone will make it. The designer must assume that all possible errors will occur and design so as to minimize the chance of the error in the first place, or its effects once it gets made. Errors should be easy to detect, they should have minimal consequences, and, if possible, their effect should be reversible. "14 In The Design of Everyday Things, D. A. Norman presents an approximate psychological model of the seven stages of action (see Figure 1 ) required to complete a task. This model helps illustrate just where a good user-interface can have its greatest effect. Clearly, the goal of an easy to use, high-quality user-interface is to simplify the process of reaching the goal. The ultimate user-interface would automatically translate the humangenerated goals directly into actions on the computer. Until a mind reading computer is developed, this is unrealistic.
Key concepts in the design process are to: 1. Provide feedback to the user immediately following the completion of a task. Such feedback helps to reinforce the conceptual, or mental, model of the function of the user-interface and the underlying software. 2. Make as much relevant information as possible visible on the screen. When all of the data is visible, the display becomes a non-immersion, virtual reality. Therefore, users can conduct experiments to test, verify, and expand their understanding of the system. (In our case, the system refers both to the interface and the drug dosing software.) 3. Enable physicians to enter data quickly and accurately and then to see the effects of changes in various parameters instantaneously. We were also interested in replacing the conversational mode of data entry in which a long series of questions was asked of the physician. If an on-line interface to a database, from which all the pertinent information from the laboratory's computer-based information management system is gleaned exists, duplicate manual data entry becomes especially annoying.
4. Reduce the possibility of making errors. Although, this may seem like an impossible task, in reality, through careful design the potential for incorrect actions can be greatly reduced. For example, sliding bars place limits on the maximum and minimum values that can be entered.
5. Translate the therapy goal directly into an action (in this case a pharmacy order). Forcing a clinician to re-enter data from the computer that helps develop the drug regimen into another that sends the order to the pharmacy is an unlikely method of gaining clinical acceptance of one's program.
IV. SYSTEM DESCRIPTION
The graphical user interface (GUI) was developed in Visual Basic 3.0 Professional edition (Microsoft, Inc.) and runs under the Windows 3.1 (Microsoft, Inc.) operating system. All patient demographic'data is stored in a relational database (Access, Microsoft, Inc.). The GUI and the database communicate via dynamic data exchange (DDE) links. Data can be entered from the GUI into the database using sliding bars to choose the appropriate values. The maximum ranges of the sliding bars are set at the upper and lower bounds of the physiologic range. In addition, once the sliding bar is selected, a brief note appears in a dialogue box informing the user of normal values for that particular field (see Figure 2) . Information on the drugs for which our interface can currently help set dosage requirements is available by clicking on the button labelled Drugs. Short monographs extracted from the Physicians' Desk Reference (PDR) are currently included (see Figure  3) . By clicking on the Patient Demo button, the physician can see a list of the patients currently on a particular unit within the hospital. Data can be changed. All changes are stored back in the database when the Return button is selected (see Figure 4 ).
Using the System
The physician first chooses the appropriate patient from a menu of patients on the unit. The selected patient's demographic information is retrieved from the local database. (Note: Currently demographic information must be entered into the local database by hand. Following implementation of the new admit/discharge/transfer (ADT) system, all demographic information will automatically be downloaded from the mainframe database over the network as new patients are admitted or transferred to the unit.) Any errors or changes (i.e., in weight or creatinine clearance, etc.) can be corrected by sliding the bar to the correct position and clicking on SAVE (which appears whenever a change is made). Following identification of the specific patient, the physician selects the drug which is to be prescribed from the list of drugs about which the system knows (currently only the model for Gentamicin is working). If the physician wants more information on the particular drug, he can click on the Drugs button to see a short monograph. The current prototype includes only a brief paragraph abstracted from the Physicians Desk Reference (PDR). As we gain more experience with the prototype, we will add additional information based on clinical needs.
The physician is now ready to set the desired peak and trough drug levels. Other key factors, such as the creatinine clearance can also be adjusted if necessary. These values are then passed to the USC*PACK software which determines the appropriate dose and timing interval based on population pharmacokinetics, if this is an initial dose, or upon the past doses and resulting serum levels if this is a continuing saga. If the physician wishes to change the dose or dosing interval (perhaps to coincide with standard clinical routines, e.g., drugs normally given every 8 hr rather than every 7.73 hr, or formularies) he simply clicks on the up or down arrow until the desired value is reached. The graph of the predicted serum levels is instantaneously adjusted to reflect these changes. By enabling the physician to see the effect of the changes instantaneously, the GUI helps the physician form an accurate mental model of the effect of this particular drug on this particular patient.
V. DISCUSSION
Status Report and Future Plans
The system is currently in an advanced prototype stage. All of the functionality described works. We are ready to begin testing the GUI with our target user group, physicians in a surgical intensive care unit. Initially we will restrict usage to one test site while we continue to refine the user-interface and test our implementation of the pharmacokinetic models.
Concurrently, we are working on a relational database to store the drug administration record and drug serum levels. We will download this information directly from the laboratory and pharmacy information systems which reside on our medical center-wide FDDI backbone network. Following our clinical tests of the interface, we plan on developing an interface back to the Shared Medical System (SMS) order entry system. Such an interface would allow the clinician to generate a pharmacy order automatically based on information derived from the bayesian modelling software. Other planned enhancements include the addition of pharmacokinetic models for other drugs. We are also developing a GUI to allow clinicians to edit/correct the data regarding the previous drug therapies and laboratory data if errors are encountered.
Lessons Learned
Use of Visual Basic 3.0 as our prototyping/development language greatly facilitated rapid changes to the system. The largely object-oriented nature of the language allows one to easily change the entire look mad feel of the system with a few simple changes to the underlying code. Use of the relational database to store all patient demographic information allows greater flexibility in searching for and displaying patient specific information. The GUI reduces the time required to enter data. The prototype graphical user-interface has allowed us to experiment with different presentation methods, greatly improving the clinical acceptance of the dosing programs.
